These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1679763)

  • 1. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.
    Shepard HM; Lewis GD; Sarup JC; Fendly BM; Maneval D; Mordenti J; Figari I; Kotts CE; Palladino MA; Ullrich A
    J Clin Immunol; 1991 May; 11(3):117-27. PubMed ID: 1679763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.
    Lewis GD; Figari I; Fendly B; Wong WL; Carter P; Gorman C; Shepard HM
    Cancer Immunol Immunother; 1993 Sep; 37(4):255-63. PubMed ID: 8102322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.
    Sarup JC; Johnson RM; King KL; Fendly BM; Lipari MT; Napier MA; Ullrich A; Shepard HM
    Growth Regul; 1991 Jun; 1(2):72-82. PubMed ID: 1688187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody.
    Kern JA; Torney L; Weiner D; Gazdar A; Shepard HM; Fendly B
    Am J Respir Cell Mol Biol; 1993 Oct; 9(4):448-54. PubMed ID: 8104437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells.
    Kumar R; Shepard HM; Mendelsohn J
    Mol Cell Biol; 1991 Feb; 11(2):979-86. PubMed ID: 1671297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
    Benz CC; Scott GK; Sarup JC; Johnson RM; Tripathy D; Coronado E; Shepard HM; Osborne CK
    Breast Cancer Res Treat; 1992; 24(2):85-95. PubMed ID: 8095168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
    Shalaby MR; Shepard HM; Presta L; Rodrigues ML; Beverley PC; Feldmann M; Carter P
    J Exp Med; 1992 Jan; 175(1):217-25. PubMed ID: 1346155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
    Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p185HER2 signal transduction in breast cancer cells.
    Scott GK; Dodson JM; Montgomery PA; Johnson RM; Sarup JC; Wong WL; Ullrich A; Shepard HM; Benz CC
    J Biol Chem; 1991 Aug; 266(22):14300-5. PubMed ID: 1677643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.
    Tsai SW; Sun Y; Williams LE; Raubitschek AA; Wu AM; Shively JE
    Bioconjug Chem; 2000; 11(3):327-34. PubMed ID: 10821648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization of an anti-p185HER2 antibody for human cancer therapy.
    Carter P; Presta L; Gorman CM; Ridgway JB; Henner D; Wong WL; Rowland AM; Kotts C; Carver ME; Shepard HM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4285-9. PubMed ID: 1350088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 186Re-labeled antibodies to p185HER2 as HER2-targeted radioimmunopharmaceutical agents: comparison of physical and biological characteristics with 125I and 131I-labeled counterparts.
    Kotts CE; Su FM; Leddy C; Dodd T; Scates S; Shalaby MR; Wirth CM; Giltinan D; Schroff RW; Fritzberg AR; Shepard HM; Slamon DJ; Hutchins BM
    Cancer Biother Radiopharm; 1996 Apr; 11(2):133-44. PubMed ID: 10851530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification.
    Tagliabue E; Centis F; Campiglio M; Mastroianni A; Martignone S; Pellegrini R; Casalini P; Lanzi C; Ménard S; Colnaghi MI
    Int J Cancer; 1991 Apr; 47(6):933-7. PubMed ID: 1672668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
    Hudziak RM; Lewis GD; Winget M; Fendly BM; Shepard HM; Ullrich A
    Mol Cell Biol; 1989 Mar; 9(3):1165-72. PubMed ID: 2566907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of breast cancer cell lines by combinations of anti-P185HER2 monoclonal antibody and cytokines.
    Kopreski MS; Lipton A; Harvey HA; Kumar R
    Anticancer Res; 1996; 16(1):433-6. PubMed ID: 8615649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.
    Park BW; Zhang HT; Wu C; Berezov A; Zhang X; Dua R; Wang Q; Kao G; O'Rourke DM; Greene MI; Murali R
    Nat Biotechnol; 2000 Feb; 18(2):194-8. PubMed ID: 10657127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer.
    Fendly BM; Kotts C; Vetterlein D; Lewis GD; Winget M; Carver ME; Watson SR; Sarup J; Saks S; Ullrich A
    J Biol Response Mod; 1990 Oct; 9(5):449-55. PubMed ID: 1979347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of anti-p185HER2 immunoliposomes for cancer therapy.
    Park JW; Hong K; Carter P; Asgari H; Guo LY; Keller GA; Wirth C; Shalaby R; Kotts C; Wood WI
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1327-31. PubMed ID: 7877976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis.
    Lewis Phillips GD; Nishimura MC; Lacap JA; Kharbanda S; Mai E; Tien J; Malesky K; Williams SP; Marik J; Phillips HS
    Breast Cancer Res Treat; 2017 Aug; 164(3):581-591. PubMed ID: 28493046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.